
This article is published in association with United Nations. The World Health Organization (WHO) on Thursday issued a medical product alert on the release of three batches of falsified semaglutides – the type of medicines primarily used to treat type 2 diabetes and obesity in some countries. The spurious semaglutides – of a specific brand Ozempic […]



















